Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...

Phase II postoperative adjuvant radiotherapy and erlotinib in patients with stage III cutaneous squamous cell carcinoma. Background: Soft tissue sarcomas account for less than 1% of all head and neck ...